EDEN vs. EML, PHC, KRPZ, WYN, CRPR, GSP, ARCM, FAR, WBI, and CTL
Should you be buying Eden Research stock or one of its competitors? The main competitors of Eden Research include Emmerson (EML), Plant Health Care (PHC), Kropz (KRPZ), Wynnstay Group (WYN), James Cropper (CRPR), Gensource Potash (GSP), Arc Minerals (ARCM), Ferro-Alloy Resources (FAR), Woodbois (WBI), and CleanTech Lithium (CTL). These companies are all part of the "basic materials" sector.
Eden Research (LON:EDEN) and Emmerson (LON:EML) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.
Emmerson's return on equity of -15.16% beat Eden Research's return on equity.
Eden Research received 86 more outperform votes than Emmerson when rated by MarketBeat users. Likewise, 64.61% of users gave Eden Research an outperform vote while only 50.88% of users gave Emmerson an outperform vote.
In the previous week, Eden Research had 7 more articles in the media than Emmerson. MarketBeat recorded 7 mentions for Eden Research and 0 mentions for Emmerson. Eden Research's average media sentiment score of 0.33 beat Emmerson's score of 0.00 indicating that Eden Research is being referred to more favorably in the media.
Emmerson has lower revenue, but higher earnings than Eden Research.
40.2% of Eden Research shares are held by institutional investors. Comparatively, 0.1% of Emmerson shares are held by institutional investors. 12.8% of Eden Research shares are held by company insiders. Comparatively, 11.3% of Emmerson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Eden Research has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, Emmerson has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500.
Summary
Eden Research beats Emmerson on 7 of the 12 factors compared between the two stocks.
Get Eden Research News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDEN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Eden Research Competitors List
Related Companies and Tools
